Email
Print
RNA Based Therapeutics Market - Forecast(2024 - 2030)
1. RNA Based Therapeutics Market - Overview
1.1 Definitions and Scope
2. RNA Based Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. RNA Based Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. RNA Based Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. RNA Based Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. RNA Based Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. RNA Based Therapeutics Market - Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
11.1 RNA Based Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 RNA Based Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 RNA Based Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 RNA Based Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 RNA Based Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. RNA Based Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. RNA Based Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. RNA Based Therapeutics Market - Key Company List by Country Premium
15. RNA Based Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Alnylam Pharmaceuticals, Inc
15.3 Benitec Biopharma Limited
15.4 Cenix Bioscience Gmbh
15.5 Dicerna Pharmaceuticals, Inc
15.6 Genzyme Corporation
15.7 Quark Pharmaceuticals, Inc
15.8 Silence Therapeutic Plc
15.9 Sirnaomics, Inc
15.10 Tekmira Pharmaceutical Corp
15.11 Company 10
15.12 Company 11 & More
16.1 Abbreviations
16.2 Sources
17. RNA Based Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. RNA Based Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. RNA Based Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. RNA Based Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. RNA Based Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. RNA Based Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. RNA Based Therapeutics Market - Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. RNA Based Therapeutics Market - By End Users (Market Size -$Million / $Billion)
8.1 Research
8.2 Therapeutic
8.3 Diagnosis
9. RNA Based Therapeutics Market - By Technology (Market Size -$Million / $Billion)
9.1 Enabling Technology
9.1.1 Microarrays
9.1.2 Labelling
9.1.3 Purification
9.1.4 Linear Amplification
9.1.5 Qrt-Pcr
9.1.6 Inhibition
9.2 Enabled Technology
9.2.1 Rna Interference Technology
9.2.2 Rna Antisense Technology
10. RNA Based Therapeutics - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Cardiovascular
10.3.2 Kidney Disease
10.3.3 Oncology
10.3.4 Infectious Disease
10.3.4.1 Tuberculosis
10.3.4.2 HIV and AIDS
10.3.5 Metabolic Disorder
10.3.5.1 Obesity
10.3.5.2 Diabetes
11. RNA Based Therapeutics - By Geography (Market Size -$Million / $Billion)11.1 RNA Based Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 RNA Based Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 RNA Based Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 RNA Based Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 RNA Based Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. RNA Based Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. RNA Based Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. RNA Based Therapeutics Market - Key Company List by Country Premium
15. RNA Based Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Alnylam Pharmaceuticals, Inc
15.3 Benitec Biopharma Limited
15.4 Cenix Bioscience Gmbh
15.5 Dicerna Pharmaceuticals, Inc
15.6 Genzyme Corporation
15.7 Quark Pharmaceuticals, Inc
15.8 Silence Therapeutic Plc
15.9 Sirnaomics, Inc
15.10 Tekmira Pharmaceutical Corp
15.11 Company 10
15.12 Company 11 & More
*Financials would be provided on a best efforts basis for private companies
16. RNA Based Therapeutics Market - Appendix16.1 Abbreviations
16.2 Sources
17. RNA Based Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Global Rna Based Therapeutic Market By Technologies, , $Million Market 2023-2030 ($M)1.1 Enabling Technology Market 2023-2030 ($M) - Global Industry Research
1.1.1 Microarrays Market 2023-2030 ($M)
1.1.2 Labelling Market 2023-2030 ($M)
1.1.3 Purification Market 2023-2030 ($M)
1.1.4 Linear Amplification Market 2023-2030 ($M)
1.1.5 Qrt-Pcr Market 2023-2030 ($M)
1.1.6 Inhibition Market 2023-2030 ($M)
1.2 Enabled Technology Market 2023-2030 ($M) - Global Industry Research
1.2.1 Rna Interference Technology Market 2023-2030 ($M)
1.2.2 Rna Antisense Technology Market 2023-2030 ($M)
2.Global Global Rna Based Therapeutic Market By End Users, , $Million Market 2023-2030 ($M)
2.1 Research Market 2023-2030 ($M) - Global Industry Research
2.2 Therapeutic Market 2023-2030 ($M) - Global Industry Research
2.3 Diagnosis Market 2023-2030 ($M) - Global Industry Research
3.Global Global Rna Based Therapeutic Market By Technologies, , $Million Market 2023-2030 (Volume/Units)
3.1 Enabling Technology Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Microarrays Market 2023-2030 (Volume/Units)
3.1.2 Labelling Market 2023-2030 (Volume/Units)
3.1.3 Purification Market 2023-2030 (Volume/Units)
3.1.4 Linear Amplification Market 2023-2030 (Volume/Units)
3.1.5 Qrt-Pcr Market 2023-2030 (Volume/Units)
3.1.6 Inhibition Market 2023-2030 (Volume/Units)
3.2 Enabled Technology Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Rna Interference Technology Market 2023-2030 (Volume/Units)
3.2.2 Rna Antisense Technology Market 2023-2030 (Volume/Units)
4.Global Global Rna Based Therapeutic Market By End Users, , $Million Market 2023-2030 (Volume/Units)
4.1 Research Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Therapeutic Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Diagnosis Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Global Rna Based Therapeutic Market By Technologies, , $Million Market 2023-2030 ($M)
5.1 Enabling Technology Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Microarrays Market 2023-2030 ($M)
5.1.2 Labelling Market 2023-2030 ($M)
5.1.3 Purification Market 2023-2030 ($M)
5.1.4 Linear Amplification Market 2023-2030 ($M)
5.1.5 Qrt-Pcr Market 2023-2030 ($M)
5.1.6 Inhibition Market 2023-2030 ($M)
5.2 Enabled Technology Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Rna Interference Technology Market 2023-2030 ($M)
5.2.2 Rna Antisense Technology Market 2023-2030 ($M)
6.North America Global Rna Based Therapeutic Market By End Users, , $Million Market 2023-2030 ($M)
6.1 Research Market 2023-2030 ($M) - Regional Industry Research
6.2 Therapeutic Market 2023-2030 ($M) - Regional Industry Research
6.3 Diagnosis Market 2023-2030 ($M) - Regional Industry Research
7.South America Global Rna Based Therapeutic Market By Technologies, , $Million Market 2023-2030 ($M)
7.1 Enabling Technology Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Microarrays Market 2023-2030 ($M)
7.1.2 Labelling Market 2023-2030 ($M)
7.1.3 Purification Market 2023-2030 ($M)
7.1.4 Linear Amplification Market 2023-2030 ($M)
7.1.5 Qrt-Pcr Market 2023-2030 ($M)
7.1.6 Inhibition Market 2023-2030 ($M)
7.2 Enabled Technology Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Rna Interference Technology Market 2023-2030 ($M)
7.2.2 Rna Antisense Technology Market 2023-2030 ($M)
8.South America Global Rna Based Therapeutic Market By End Users, , $Million Market 2023-2030 ($M)
8.1 Research Market 2023-2030 ($M) - Regional Industry Research
8.2 Therapeutic Market 2023-2030 ($M) - Regional Industry Research
8.3 Diagnosis Market 2023-2030 ($M) - Regional Industry Research
9.Europe Global Rna Based Therapeutic Market By Technologies, , $Million Market 2023-2030 ($M)
9.1 Enabling Technology Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Microarrays Market 2023-2030 ($M)
9.1.2 Labelling Market 2023-2030 ($M)
9.1.3 Purification Market 2023-2030 ($M)
9.1.4 Linear Amplification Market 2023-2030 ($M)
9.1.5 Qrt-Pcr Market 2023-2030 ($M)
9.1.6 Inhibition Market 2023-2030 ($M)
9.2 Enabled Technology Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Rna Interference Technology Market 2023-2030 ($M)
9.2.2 Rna Antisense Technology Market 2023-2030 ($M)
10.Europe Global Rna Based Therapeutic Market By End Users, , $Million Market 2023-2030 ($M)
10.1 Research Market 2023-2030 ($M) - Regional Industry Research
10.2 Therapeutic Market 2023-2030 ($M) - Regional Industry Research
10.3 Diagnosis Market 2023-2030 ($M) - Regional Industry Research
11.APAC Global Rna Based Therapeutic Market By Technologies, , $Million Market 2023-2030 ($M)
11.1 Enabling Technology Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Microarrays Market 2023-2030 ($M)
11.1.2 Labelling Market 2023-2030 ($M)
11.1.3 Purification Market 2023-2030 ($M)
11.1.4 Linear Amplification Market 2023-2030 ($M)
11.1.5 Qrt-Pcr Market 2023-2030 ($M)
11.1.6 Inhibition Market 2023-2030 ($M)
11.2 Enabled Technology Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Rna Interference Technology Market 2023-2030 ($M)
11.2.2 Rna Antisense Technology Market 2023-2030 ($M)
12.APAC Global Rna Based Therapeutic Market By End Users, , $Million Market 2023-2030 ($M)
12.1 Research Market 2023-2030 ($M) - Regional Industry Research
12.2 Therapeutic Market 2023-2030 ($M) - Regional Industry Research
12.3 Diagnosis Market 2023-2030 ($M) - Regional Industry Research
13.MENA Global Rna Based Therapeutic Market By Technologies, , $Million Market 2023-2030 ($M)
13.1 Enabling Technology Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Microarrays Market 2023-2030 ($M)
13.1.2 Labelling Market 2023-2030 ($M)
13.1.3 Purification Market 2023-2030 ($M)
13.1.4 Linear Amplification Market 2023-2030 ($M)
13.1.5 Qrt-Pcr Market 2023-2030 ($M)
13.1.6 Inhibition Market 2023-2030 ($M)
13.2 Enabled Technology Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Rna Interference Technology Market 2023-2030 ($M)
13.2.2 Rna Antisense Technology Market 2023-2030 ($M)
14.MENA Global Rna Based Therapeutic Market By End Users, , $Million Market 2023-2030 ($M)
14.1 Research Market 2023-2030 ($M) - Regional Industry Research
14.2 Therapeutic Market 2023-2030 ($M) - Regional Industry Research
14.3 Diagnosis Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US RNA Based Therapeutics Market Revenue, 2023-2030 ($M)2.Canada RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
3.Mexico RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
4.Brazil RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
5.Argentina RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
6.Peru RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
7.Colombia RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
8.Chile RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
9.Rest of South America RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
10.UK RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
11.Germany RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
12.France RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
13.Italy RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
14.Spain RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
15.Rest of Europe RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
16.China RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
17.India RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
18.Japan RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
19.South Korea RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
20.South Africa RNA Based Therapeutics Market Revenue, 2023-2030 ($M)
21.North America RNA Based Therapeutics By Application
22.South America RNA Based Therapeutics By Application
23.Europe RNA Based Therapeutics By Application
24.APAC RNA Based Therapeutics By Application
25.MENA RNA Based Therapeutics By Application
26.Quark Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Alnylam Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Dicerna Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Tekmira Pharmaceutical Corp, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Benitec Biopharma Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Cenix Bioscience Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Genzyme Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Silence Therapeutic Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Sirnaomics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)